Ikarian Healthcare Master Fund, L.p. - Net Worth and Insider Trading
Ikarian Healthcare Master Fund, L.p. Net Worth
The estimated net worth of Ikarian Healthcare Master Fund, L.p. is at least $7,852 dollars as of 2024-11-13. Ikarian Healthcare Master Fund, L.p. is the of TRACON Pharmaceuticals Inc and owns about 135,842 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $7,852. Details can be seen in Ikarian Healthcare Master Fund, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ikarian Healthcare Master Fund, L.p. has not made any transactions after 2020-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ikarian Healthcare Master Fund, L.p.
Ikarian Healthcare Master Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ikarian Healthcare Master Fund, L.p. owns 1 companies in total, including TRACON Pharmaceuticals Inc (TCON) .
Insider Ownership Summary of Ikarian Healthcare Master Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2020-12-30 | 10 percent owner & other: Member of 10% Group |
Ikarian Healthcare Master Fund, L.p. Latest Holdings Summary
Ikarian Healthcare Master Fund, L.p. currently owns a total of 1 stock. Ikarian Healthcare Master Fund, L.p. owns 135,842 shares of TRACON Pharmaceuticals Inc (TCON) as of December 30, 2020, with a value of $7,852.
Latest Holdings of Ikarian Healthcare Master Fund, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2020-12-30 | 135,842 | 0.06 | 7,852 |
Holding Weightings of Ikarian Healthcare Master Fund, L.p.
Ikarian Healthcare Master Fund, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Ikarian Healthcare Master Fund, L.p. has made a total of 4 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 26,015 shares on December 30, 2020, which cost Ikarian Healthcare Master Fund, L.p. around $5 Million.
Insider Trading History of Ikarian Healthcare Master Fund, L.p.
- 1
Ikarian Healthcare Master Fund, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Ikarian Healthcare Master Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ikarian Healthcare Master Fund, L.p. is 50.04%. GuruFocus also compares Ikarian Healthcare Master Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Ikarian Healthcare Master Fund, L.p. within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ikarian Healthcare Master Fund, L.p.'s insider trading performs compared to the benchmark.
Performance of Ikarian Healthcare Master Fund, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.37 | | | | | |
| Relative Return to S&P 500(%) | 4.82 | | | | | |
Ikarian Healthcare Master Fund, L.p. Ownership Network
Ownership Network List of Ikarian Healthcare Master Fund, L.p.
Ownership Network Relation of Ikarian Healthcare Master Fund, L.p.
Ikarian Healthcare Master Fund, L.p. Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Ikarian Healthcare Master Fund, L.p. is the 10 percent owner & other: Member of 10% Group of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Ikarian Healthcare Master Fund, L.p. made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Ikarian Healthcare Master Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Ikarian Healthcare Master Fund, L.p.. You might contact Ikarian Healthcare Master Fund, L.p. via mailing address: 100 Crescent Court, Suite 1620, Dallas Tx 75201.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
